advertisement

Society

Monthly injections to save patients from oral ARVs

Anti-retroviral drugs. FILE PHOTO | NMG
Anti-retroviral drugs. FILE PHOTO | NMG  

HIV patients tired of swallowing daily oral tablets may soon benefit from alternative long-lasting treatments administered once or twice per month.

Findings of a new phase 2 trial study published in The Lancet journal show that an injectable antiretroviral (ARV) therapy consisting of two drugs (cabotegravir and rilpivirine) — administered every four or eight weeks — may be as effective as a daily oral dose of the drugs in maintaining viral suppression among HIV patients.

The researchers stated that the potential for long-acting injectable ARVs could ease the burden faced by people living with HIV of having to take daily oral medication to manage the disease throughout their lives.

advertisement